Bulletin
Investor Alert

New York Markets Close in:

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 30, 2023, 9:44 a.m.

/zigman2/quotes/203509482/composite

$

211.84

Change

-2.19 -1.02%

Volume

Volume 20,577

Real time quotes

/zigman2/quotes/203509482/composite

Previous close

$ 214.03

$ 211.84

Change

-2.19 -1.02%

Day low

Day high

$210.77

$212.06

Open

52 week low

52 week high

$173.45

$371.16

Open

Insider Actions for Illumina Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/09/2023 Aimee Hoyt
SVP, Chief People Officer
871   Disposition at $205.57 per share. 179,051
01/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer
500   Disposition at $204.58 per share. 102,290
12/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer
500   Disposition at $212.63 per share. 106,315
11/08/2022 Alex Aravanis
SVP, Chief Technology Officer
361   Disposition at $218 per share. 78,698
11/07/2022 Susan H. Tousi
SVP, Chief Commercial Officer
500   Disposition at $223.65 per share. 111,825
11/07/2022 Aimee Hoyt
SVP, Chief People Officer
1,045   Disposition at $223.65 per share. 233,714
11/07/2022 Aimee Hoyt
SVP, Chief People Officer
1,294   Disposition at $223.65 per share. 289,403
11/05/2022 Francis A. deSouza
President and CEO; Director
2,591   Derivative/Non-derivative trans. at $217.19 per share. 562,739
11/05/2022 Susan H. Tousi
SVP, Chief Commercial Officer
721   Derivative/Non-derivative trans. at $217.19 per share. 156,593
11/05/2022 Joydeep Goswami
SVP Corp Business Development
638   Derivative/Non-derivative trans. at $217.19 per share. 138,567
11/05/2022 Charles E. Dadswell
SVP & General Counsel
853   Derivative/Non-derivative trans. at $217.19 per share. 185,263
11/05/2022 Kevin Pegels
Chief of Global Operations
472   Derivative/Non-derivative trans. at $217.19 per share. 102,513
11/05/2022 Scott Ericksen
VP, Chief Accounting Officer
213   Derivative/Non-derivative trans. at $217.19 per share. 46,261
11/05/2022 Phillip G. Febbo
SVP Chief Medical Officer
821   Derivative/Non-derivative trans. at $217.19 per share. 178,312
11/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer
212   Derivative/Non-derivative trans. at $217.19 per share. 46,044
11/05/2022 Aimee Hoyt
SVP, Chief People Officer
640   Derivative/Non-derivative trans. at $217.19 per share. 139,001
11/05/2022 Alex Aravanis
SVP, Chief Technology Officer
191   Derivative/Non-derivative trans. at $217.19 per share. 41,483
10/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer
500   Disposition at $216.59 per share. 108,295
10/05/2022 Joydeep Goswami
SVP Corp Business Development
165   Derivative/Non-derivative trans. at $218.52 per share. 36,055
10/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer
73   Derivative/Non-derivative trans. at $218.52 per share. 15,951
07/07/2022 Alex Aravanis
SVP, Chief Technology Officer
539   Disposition at $200 per share. 107,800
07/05/2022 Alex Aravanis
SVP, Chief Technology Officer
285   Derivative/Non-derivative trans. at $193.02 per share. 55,010

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
17 Sales
0
12,423
Last 6 months
0 Purchases
20 Sales
0
13,161
Last 12 months
26 Purchases
46 Sales
73,250
38,883

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Kevin Pegels
Chief-Global Operations
Dr. Joydeep Goswami
Chief Financial & Strategy Officer
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Ms. Carissa Rollins
Chief Information Officer
Dr. Phillip G. Febbo
Chief Medical Officer
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Dr. Bryan Crane
Vice President & Head-System Design
Mr. Charles E. Dadswell
Secretary & General Counsel
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathryne Reeves
Chief Marketing Officer
Mr. Scott Ericksen
Ms. Sallilyn Schwartz
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Mr. John Frank
Chief Public Affairs Officer
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.